A simple algorithm designed to recommend highly effective disease-modifying therapies (DMTs) for multiple sclerosis (MS) patients can help ensure fairer treatment and reduce racial and ethnic disparities, according to a new study by U.S. researchers.
Black individuals with multiple sclerosis (MS) tend to walk more slowly and cover less distance within a set time than their white counterparts, according to a U.S. study.
Read moreDetails